These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3341527)

  • 1. Predictors of total and low-density lipoprotein cholesterol change after partial ileal bypass.
    Campos CT; Matts JP; Santilli SM; Fitch LL; Long JM; Speech JC; Buchwald H
    Am J Surg; 1988 Jan; 155(1):138-46. PubMed ID: 3341527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of ileal bypass on lipoproteins in patients with familial hypercholesterolemia.
    Koivisto P; Miettinen TA
    Circulation; 1984 Aug; 70(2):290-6. PubMed ID: 6733883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein modification achieved by partial ileal bypass: five-year results of The Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1987 Aug; 102(2):424-32. PubMed ID: 3303402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein catabolism in WHHL rabbits after partial ileal bypass surgery.
    Mol MJ; Stalenhoef AF; Demacker PN; van't Laar A
    Biochim Biophys Acta; 1989 Jun; 1003(2):167-74. PubMed ID: 2730889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of partial ileal bypass on plasma lipoproteins.
    Moore RB; Buchwald H; Varco RL
    Circulation; 1980 Sep; 62(3):469-76. PubMed ID: 7398005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Varco RL; Boen JR; Williams SE; Hansen BJ; Campos CT; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD; Sawin HS
    Arch Intern Med; 1998 Jun; 158(11):1253-61. PubMed ID: 9625405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of partial ileal bypass for the treatment of familial hypercholesterolemia.
    Ohri SK; Keane PF; Swift I; Sackier JM; Williamson RC; Thompson GR; Wood CB
    Am J Gastroenterol; 1989 Jul; 84(7):740-3. PubMed ID: 2741883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The partial ileal bypass in the treatment of familial hypercholesterolemia].
    Lebedev LV; Sedletskiĭ IuI; Mirchuk KK
    Vestn Khir Im I I Grek; 1993; 150(5-6):30-3. PubMed ID: 8091575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Partial ileal bypass for familial hypercholesterolemia].
    Basson JJ; Nel CJ; De Wet JI; Monk EJ
    S Afr J Surg; 1992 Dec; 30(4):145-7. PubMed ID: 1295095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.
    Spengel FA; Jadhav A; Duffield RG; Wood CB; Thompson GR
    Lancet; 1981 Oct; 2(8250):768-70. PubMed ID: 6116902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.